0001916558 2025-01-01 2025-12-31 0001916558 2025-12-31 0001916558 2026-03-31 0001916558 2024-01-01 2024-12-31 0001916558 2024-12-31 0001916558 us-gaap:CommonStockMember 2022-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001916558 us-gaap:RetainedEarningsMember 2022-12-31 0001916558 2022-12-31 0001916558 us-gaap:CommonStockMember 2023-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001916558 us-gaap:RetainedEarningsMember 2023-12-31 0001916558 2023-12-31 0001916558 us-gaap:CommonStockMember 2024-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001916558 us-gaap:RetainedEarningsMember 2024-12-31 0001916558 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001916558 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001916558 2023-01-01 2023-12-31 0001916558 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001916558 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001916558 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-12-31 0001916558 us-gaap:RetainedEarningsMember 2025-01-01 2025-12-31 0001916558 us-gaap:CommonStockMember 2025-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001916558 us-gaap:RetainedEarningsMember 2025-12-31 0001916558 TRWD:AIAppMember 2025-12-31 0001916558 TRWD:FormulaPetsMember 2025-12-31 0001916558 us-gaap:TrademarksMember 2025-12-31 0001916558 TRWD:WebsiteMember 2025-12-31 0001916558 TRWD:FormulaPetsIntangibleAssetMember 2024-12-31 0001916558 TRWD:FormulaPetsIntangibleAssetMember 2024-01-01 2024-12-31 0001916558 TRWD:CommonStocksMember 2025-01-01 2025-12-31 0001916558 TRWD:AdditionalPaidInCapitalsMember 2025-01-01 2025-12-31 0001916558 TRWD:NonAffiliatedEntityMember 2025-06-07 2025-06-08 0001916558 TRWD:NonAffiliatedIndividualMember 2025-06-07 2025-06-09 0001916558 TRWD:NonAffiliatedIndividualMember 2025-07-04 2025-07-05 0001916558 TRWD:NonAffiliatedEntityMember 2025-07-07 2025-07-08 0001916558 TRWD:NonAffiliatedIndividualMember 2025-07-28 2025-07-29 0001916558 TRWD:NonAffiliatedEntityMember 2025-08-19 2025-08-20 0001916558 TRWD:NonAffiliatedIndividualMember 2025-09-22 2025-09-23 0001916558 TRWD:NonAffiliatedEntityMember 2025-10-09 2025-10-10 0001916558 TRWD:CommonStocksMember 2025-10-15 0001916558 TRWD:NonAffiliatedEntityMember 2025-10-14 2025-10-15 0001916558 TRWD:NonAffiliatedIndividualMember 2025-10-29 2025-11-01 0001916558 TRWD:NonAffiliatedIndividualMember 2025-11-02 2025-11-03 0001916558 TRWD:NonAffiliatedIndividualMember 2025-11-11 2025-11-12 0001916558 TRWD:NonAffiliatedIndividualMember 2025-11-27 2025-11-28 0001916558 TRWD:AndrewReadMember 2022-02-04 2022-02-05 0001916558 TRWD:AndrewReadMember 2022-02-05 0001916558 TRWD:AndrewReadMember 2023-12-27 2023-12-28 0001916558 TRWD:AndrewReadMember 2023-12-28 0001916558 2022-03-11 0001916558 2022-03-10 2022-03-11 0001916558 TRWD:InvestorsMember 2022-03-11 0001916558 TRWD:WarrantsMember 2025-01-01 2025-12-31 0001916558 TRWD:WarrantsMember 2025-12-31 0001916558 TRWD:Warrants1Member 2025-01-01 2025-12-31 0001916558 TRWD:Warrants1Member 2025-12-31 0001916558 TRWD:Warrants2Member 2025-01-01 2025-12-31 0001916558 TRWD:Warrants2Member 2025-12-31 0001916558 TRWD:Warrants3Member 2025-01-01 2025-12-31 0001916558 TRWD:Warrants3Member 2025-12-31 0001916558 us-gaap:SubsequentEventMember TRWD:PurchaseAgreementMember 2026-01-28 2026-01-29 0001916558 us-gaap:SubsequentEventMember TRWD:PurchaseAgreementMember 2026-01-29 0001916558 2025-10-01 2025-12-31 iso4217:USD shares iso4217:USD shares pure TRWD:Integer false 2025 FY 0001916558

10-K true 2025-12-31 --12-31 false 333-276233 Tradewinds Universal WY 87-4254479 501 Mercury Lane Brea CA 92821 855 434-4488 No No Yes Yes Non-accelerated Filer true true false false false false 2046058 43690580 Risk Management and Strategy We periodically assess risks from cybersecurity threats, and monitor our information systems for potential vulnerabilities. However, to date, given the small size of our company and the nature of our operations, our reliance on information systems has been limited to the use of standard off-the-shelf software (such as Google, QuickBooks and Microsoft Office) and the use by our employees of standard personal computers. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20250101__20251231_z1A14ddn55e7">Accordingly, management has not <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbF_c20250101__20251231_zisD3DXhobi5">implemented any formal process for assessing, identifying, and managing risks from cybersecurity threats. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20250101__20251231_z85INNUBfzng">Risks from cybersecurity threats have, to date, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20250101__20251231_zdb2kLHU0Pid">not materially affected us, our business strategy, results of operations or financial condition. Accordingly, management has not <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbF_c20250101__20251231_zisD3DXhobi5">implemented any formal process for assessing, identifying, and managing risks from cybersecurity threats. false Risks from cybersecurity threats have, to date, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20250101__20251231_zdb2kLHU0Pid">not materially affected us, our business strategy, results of operations or financial condition. false Governance <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zYpR432ln4jb">As discussed above, given the nature of our current operations and our experience to date, we do not currently perceive cybersecurity as a particularly significant risk to our business. Accordingly, we have not tasked our Board of Directors with any additional cybersecurity oversight duties, or designated any committee of the Board of Directors to specifically oversee cybersecurity risks to our business. As discussed above, given the nature of our current operations and our experience to date, we do not currently perceive cybersecurity as a particularly significant risk to our business. Accordingly, we have not tasked our Board of Directors with any additional cybersecurity oversight duties, or designated any committee of the Board of Directors to specifically oversee cybersecurity risks to our business. 5525 6920 Fruci & Associates II, PLLC Spokane, Washington Astra Audit & Advisory LLC Tampa, FL

16638

210

25445

48750

90833

210

190000

31300

25000 0 1500 0

216500

31300

307333

31510

0.001

75000000

42690580

32170000

42691

32170

1447709

289530

-1183067

-290190

307333

31510

307333

31510

133222

171596

21645

133222

149951

60695

148093

33108

51838

886105

5133

14800

4800

31392

4459

5000

1026099

219323

-892877

-69372

-0

46371

-892877

-115743

-0.01

35527656

32170000

6970000

6970

62730

7744

77444

22000000

22000

198000

220000

3200000

3200

28800

32000

-182191

32170000

32170

289530

-174447

147253

-115743

32170000

32170

289530

-290190

31510

9400000

9400

885300

894700

946667

947

73053

74000

173913

174

199826

200000

-892877

42690580

42691

1447709

-1183067

307333

-892877

-115743

46371

14800

4800

894700

5000

-0

-18076

25445

-13493

48750

-0

-57572

-28003

-0

74000

16428

-28003

210

28213

16638

210

25445 0 200000 0

Note 1 – Nature of Operations Nature of Operations Tradewinds Universal, Inc. (the “Company”) was incorporated in the State of Wyoming on December 28, 2021. The Company operates as a holding company focused on acquiring, developing, and managing businesses with long-term value, resilience, and growth potential. The Company’s initial operations focused on the development and distribution of high-nutrition foods and beverages, including edible insect protein-based products. In 2022, the Company acquired a canine pain relief formula for development into pet-related products. During the year ended December 31, 2025, the Company expanded its strategic focus to include distribution and licensing activities. In August 2025, the Company signed a Letter of Intent with Peppermint Hippo™, a company that generates an estimated $30 million in annual revenue, to launch a nightlife and hospitality division. This will begin with the planned acquisition of Peppermint Hippo Toledo and a staged rollout of several additional clubs across the country.

Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying audited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company’s financial position, results of operations, and cash flows for the years ended December 31, 2025 and December 31, 2024 have been included. Estimates The preparation of the financial statement in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts. Accordingly, actual results could differ from those estimates. Cash And Cash Equivalents The Company maintains a cash balance in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2025 and December 31, 2024. Accounts Receivable Accounts receivable consist of trade receivables and are stated at the amount management expects to collect. As of December 31, 2025, accounts receivable totaled $48,750 and were due from one customer. There were no accounts receivable as of December 31, 2024. The Company evaluates accounts receivable for expected credit losses in accordance with ASC 326, Financial Instruments—Credit Losses. In estimating expected credit losses, management considers relevant available information, including historical collection experience, the financial condition and creditworthiness of the customer, current economic conditions, and reasonable and supportable forecasts of future conditions that may affect collectibility. Because the Company had no prior history of credit losses, the receivable balance at December 31, 2025 was due from a single customer with no history of delinquency or default, and management was not aware of any current or expected future events that would materially affect the customer’s ability to pay, no allowance for credit losses was recorded as of December 31, 2025. All accounts receivable were considered collectible. Prepaid Expenses Prepaid expenses consist primarily of payments made for services to be received in future periods and are expensed as the services are consumed. As of December 31, 2025, prepaid expenses totaled $25,445. There were no prepaid expenses as of December 31, 2024. Intangible Asset Intangible assets are recorded at cost and amortized over their estimated useful lives unless determined to have an indefinite useful life. For definite-lived intangible assets, the Company evaluates impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If such indicators are present, the Company compares the expected undiscounted future cash flows attributable to the asset to its carrying amount. If the carrying amount exceeds the expected undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset’s fair value. Indefinite-lived intangible assets are not amortized but are evaluated for impairment at least annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. An impairment loss is recognized for the amount by which the carrying value exceeds the asset’s estimated fair value. As of December 31, 2025, the Company’s intangible assets consisted of the following: <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>AI App, net $190,000</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Formula-Pets $25,000</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Trademarks $1,500</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Website, net $0</td></tr></table> Total intangible assets at gross amounted to $233,900. Accumulated amortization totaled $14,800, and the Company recorded an impairment loss of $5,000 related to the Formula – Pets intangible asset at year ended December 31, 2024. Total intangible assets, net, were $216,500 as of December 31, 2025. There was no impairment recorded as of December 31, 2025. As of December 31, 2024, the Company’s intangible assets consisted of intangible assets of $<span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaPetsIntangibleAssetMember_zWDGbg6EXq2k" title="Intangible assets, net">31,300 and the Company recorded an impairment loss of $<span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20240101__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaPetsIntangibleAssetMember_zGowXUVnRO3c" title="Loss of impairment of intangible assets">5,000 related to the Formula – Pets intangible asset. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company’s AI application is amortized over five years, and the Company’s website was amortized over two years. As of December 31, 2025, the website was fully amortized. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Amortization expense for the year ended December 31, 2025 was $14,800, and amortization expense for the year ended December 31, 2024 was $4,800. Stock Compensation The Company accounts for stock-based compensation in accordance with ASC 718, Compensation—Stock Compensation. Stock-based compensation expense is recognized based on the fair value of equity instruments issued. The Company is authorized to issue 75,000,000 shares of common stock, par value .001 per share. As of December 31, 2025, there were 42,690,580 shares of common stock issued and outstanding. (See: Note 5 Shareholders' Equity) The Company issued 9,400,000 shares of common stock as compensation for services during the year ended December 31, 2025 There were no shares issued for services during the year ended December 31, 2024. Impairment Of Long-Lived Assets The Company accounts for impairment of intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Definite-lived intangible assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate potential impairment. During the year ended December 31, 2024, the Company recorded an impairment charge of $5,000 related to the Formula-Pets intangible asset. No impairment charge was recorded during the year ended December 31, 2025. As of December 31, 2025, the carrying value of the Formula-Pets intangible asset was $<span id="xdx_907_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_do_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaPetsMember_zTbRt618f8D3" title="Carrying value intangible asset">25,000. Revenue Recognition The Company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in determining revenue recognition: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when, or as, the Company satisfies a performance obligation. The Company’s revenue is derived primarily from distribution rights, licenses, and affiliate commissions. For each contract, the Company first determines whether an arrangement exists that creates enforceable rights and obligations. The Company then identifies the distinct performance obligations promised in the contract. The transaction price is determined based on the consideration the Company expects to receive under the terms of the arrangement, including fixed amounts and, when applicable, estimates of variable consideration to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. When a contract contains more than one performance obligation, the transaction price is allocated to each performance obligation based on its relative standalone selling price. Revenue from distribution rights is recognized at the point in time or over the period in which the customer obtains control of the contractual rights, depending on the nature of the arrangement and the Company’s performance obligations under the contract. Revenue from licenses is recognized when the licensed intellectual property is made available to the customer or over the license term, depending on whether the license provides a right to use intellectual property as it exists at a point in time or a right to access intellectual property as it evolves over time. Revenue from affiliate commissions is recognized at the time the underlying qualifying transaction occurs and the commission is earned, which is the point at which the Company’s performance obligation is satisfied. The Company evaluates each contract to determine whether it acts as principal or agent, as applicable, and records revenue on a gross or net basis consistent with that determination. Payment terms vary by contract but are generally due within 30 to 90 days. Amounts billed and collected in advance of satisfying the related performance obligations are recorded as deferred revenue. Fair Value of Financial Instruments ASC 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. The carrying amounts of cash and cash equivalents, accounts payable, and accrued liabilities approximate fair value because of the short-term maturities of these instruments. The Company applies ASC 820, Fair Value Measurement, which establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels: Level 1, quoted prices in active markets for identical assets or liabilities; Level 2, observable inputs other than quoted prices included in Level 1; and Level 3, unobservable inputs reflecting the Company’s own assumptions. The Company did not elect the fair value option for any eligible assets or liabilities under ASC 825. As of December 31, 2025 and 2024, the Company had no financial instruments measured at fair value on a recurring basis. Income Taxes In accordance with ASC 740 Income Taxes, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in Income in the period that includes the enactment date. The Company has adopted the provisions set forth in ASC 740 to account for uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of the income tax law. The taxing authorities may challenge such positions, and the resolution of such matters could result in recognition of Income tax expense in the Company's financial statements. Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns. The Company uses the "more likely than not" criterion for recognizing the tax benefit of uncertain tax positions and to establish measurement criteria for income tax benefits. The Company' s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on its balance sheets as of December 31, 2025, and December 31, 2024. The Company has incurred net operating losses and has established a full valuation allowance against its deferred tax assets. As a result, no income tax expense or benefit was recorded for the years ended December 31, 2025 or December 31, 2024. Earnings Per Share of Common Stock Net loss per share is computed in accordance with ASC 260, Earnings Per Share. Basic and diluted net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Potentially dilutive securities were excluded from the calculation as their effect would be anti-dilutive. Recently Adopted Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances annual income tax disclosure requirements. For public business entities, the amendments are effective for annual periods beginning after December 15, 2024. Accordingly, the Company adopted ASU 2023-09 for the year ended December 31, 2025. The adoption of this standard did not have an effect on the Company’s financial position, results of operations, or cash flows, but required expanded annual income tax disclosures.

Basis of Presentation The accompanying audited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company’s financial position, results of operations, and cash flows for the years ended December 31, 2025 and December 31, 2024 have been included.

Estimates The preparation of the financial statement in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts. Accordingly, actual results could differ from those estimates.

Cash And Cash Equivalents The Company maintains a cash balance in a non-interest-bearing account that currently does not exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2025 and December 31, 2024.

Accounts Receivable Accounts receivable consist of trade receivables and are stated at the amount management expects to collect. As of December 31, 2025, accounts receivable totaled $48,750 and were due from one customer. There were no accounts receivable as of December 31, 2024. The Company evaluates accounts receivable for expected credit losses in accordance with ASC 326, Financial Instruments—Credit Losses. In estimating expected credit losses, management considers relevant available information, including historical collection experience, the financial condition and creditworthiness of the customer, current economic conditions, and reasonable and supportable forecasts of future conditions that may affect collectibility. Because the Company had no prior history of credit losses, the receivable balance at December 31, 2025 was due from a single customer with no history of delinquency or default, and management was not aware of any current or expected future events that would materially affect the customer’s ability to pay, no allowance for credit losses was recorded as of December 31, 2025. All accounts receivable were considered collectible.

48750

Prepaid Expenses Prepaid expenses consist primarily of payments made for services to be received in future periods and are expensed as the services are consumed. As of December 31, 2025, prepaid expenses totaled $25,445. There were no prepaid expenses as of December 31, 2024.

25445

Intangible Asset Intangible assets are recorded at cost and amortized over their estimated useful lives unless determined to have an indefinite useful life. For definite-lived intangible assets, the Company evaluates impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If such indicators are present, the Company compares the expected undiscounted future cash flows attributable to the asset to its carrying amount. If the carrying amount exceeds the expected undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset’s fair value. Indefinite-lived intangible assets are not amortized but are evaluated for impairment at least annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. An impairment loss is recognized for the amount by which the carrying value exceeds the asset’s estimated fair value. As of December 31, 2025, the Company’s intangible assets consisted of the following: <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>AI App, net $190,000</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Formula-Pets $25,000</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Trademarks $1,500</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Website, net $0</td></tr></table> Total intangible assets at gross amounted to $233,900. Accumulated amortization totaled $14,800, and the Company recorded an impairment loss of $5,000 related to the Formula – Pets intangible asset at year ended December 31, 2024. Total intangible assets, net, were $216,500 as of December 31, 2025. There was no impairment recorded as of December 31, 2025. As of December 31, 2024, the Company’s intangible assets consisted of intangible assets of $<span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaPetsIntangibleAssetMember_zWDGbg6EXq2k" title="Intangible assets, net">31,300 and the Company recorded an impairment loss of $<span id="xdx_904_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20240101__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaPetsIntangibleAssetMember_zGowXUVnRO3c" title="Loss of impairment of intangible assets">5,000 related to the Formula – Pets intangible asset. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company’s AI application is amortized over five years, and the Company’s website was amortized over two years. As of December 31, 2025, the website was fully amortized. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Amortization expense for the year ended December 31, 2025 was $14,800, and amortization expense for the year ended December 31, 2024 was $4,800.

190000

25000

1500

233900

14800

5000

216500

31300

5000

14800

4800

Stock Compensation The Company accounts for stock-based compensation in accordance with ASC 718, Compensation—Stock Compensation. Stock-based compensation expense is recognized based on the fair value of equity instruments issued. The Company is authorized to issue 75,000,000 shares of common stock, par value .001 per share. As of December 31, 2025, there were 42,690,580 shares of common stock issued and outstanding. (See: Note 5 Shareholders' Equity) The Company issued 9,400,000 shares of common stock as compensation for services during the year ended December 31, 2025 There were no shares issued for services during the year ended December 31, 2024.

75000000

0.001

42690580

9400000 0

Impairment Of Long-Lived Assets The Company accounts for impairment of intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Definite-lived intangible assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate potential impairment. During the year ended December 31, 2024, the Company recorded an impairment charge of $5,000 related to the Formula-Pets intangible asset. No impairment charge was recorded during the year ended December 31, 2025. As of December 31, 2025, the carrying value of the Formula-Pets intangible asset was $<span id="xdx_907_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_do_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaPetsMember_zTbRt618f8D3" title="Carrying value intangible asset">25,000.

5000

25000

Revenue Recognition The Company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in determining revenue recognition: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when, or as, the Company satisfies a performance obligation. The Company’s revenue is derived primarily from distribution rights, licenses, and affiliate commissions. For each contract, the Company first determines whether an arrangement exists that creates enforceable rights and obligations. The Company then identifies the distinct performance obligations promised in the contract. The transaction price is determined based on the consideration the Company expects to receive under the terms of the arrangement, including fixed amounts and, when applicable, estimates of variable consideration to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. When a contract contains more than one performance obligation, the transaction price is allocated to each performance obligation based on its relative standalone selling price. Revenue from distribution rights is recognized at the point in time or over the period in which the customer obtains control of the contractual rights, depending on the nature of the arrangement and the Company’s performance obligations under the contract. Revenue from licenses is recognized when the licensed intellectual property is made available to the customer or over the license term, depending on whether the license provides a right to use intellectual property as it exists at a point in time or a right to access intellectual property as it evolves over time. Revenue from affiliate commissions is recognized at the time the underlying qualifying transaction occurs and the commission is earned, which is the point at which the Company’s performance obligation is satisfied. The Company evaluates each contract to determine whether it acts as principal or agent, as applicable, and records revenue on a gross or net basis consistent with that determination. Payment terms vary by contract but are generally due within 30 to 90 days. Amounts billed and collected in advance of satisfying the related performance obligations are recorded as deferred revenue.

Fair Value of Financial Instruments ASC 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. The carrying amounts of cash and cash equivalents, accounts payable, and accrued liabilities approximate fair value because of the short-term maturities of these instruments. The Company applies ASC 820, Fair Value Measurement, which establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels: Level 1, quoted prices in active markets for identical assets or liabilities; Level 2, observable inputs other than quoted prices included in Level 1; and Level 3, unobservable inputs reflecting the Company’s own assumptions. The Company did not elect the fair value option for any eligible assets or liabilities under ASC 825. As of December 31, 2025 and 2024, the Company had no financial instruments measured at fair value on a recurring basis.

Income Taxes In accordance with ASC 740 Income Taxes, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in Income in the period that includes the enactment date. The Company has adopted the provisions set forth in ASC 740 to account for uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of the income tax law. The taxing authorities may challenge such positions, and the resolution of such matters could result in recognition of Income tax expense in the Company's financial statements. Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns. The Company uses the "more likely than not" criterion for recognizing the tax benefit of uncertain tax positions and to establish measurement criteria for income tax benefits. The Company' s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on its balance sheets as of December 31, 2025, and December 31, 2024. The Company has incurred net operating losses and has established a full valuation allowance against its deferred tax assets. As a result, no income tax expense or benefit was recorded for the years ended December 31, 2025 or December 31, 2024.

Earnings Per Share of Common Stock Net loss per share is computed in accordance with ASC 260, Earnings Per Share. Basic and diluted net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Potentially dilutive securities were excluded from the calculation as their effect would be anti-dilutive.

Recently Adopted Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances annual income tax disclosure requirements. For public business entities, the amendments are effective for annual periods beginning after December 15, 2024. Accordingly, the Company adopted ASU 2023-09 for the year ended December 31, 2025. The adoption of this standard did not have an effect on the Company’s financial position, results of operations, or cash flows, but required expanded annual income tax disclosures.

Note 3 - Commitments and Contingencies During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with ASC 450, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of December 31, 2025, and December 31, 2024, the Company is not aware of any contingent liabilities that should be reflected in the audited financial statements.

Note 4 - Segment Disclosure ASC 280 “Segment Reporting ”, establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the CODM in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one reportable segment and unit and derives revenues mainly from products, licensing rights and affiliate commissions (see Note 1 for a brief description of the Company’s business). The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the CODM, which is the Company’s chief executive officer, who reviews financial information and annual operating plans for purposes of making operating decisions, evaluating financial performance, and allocating resources. The key measure of segment profit or loss that the CODM uses to allocate resources and assess performance is the Company’s net income (loss). This is reviewed against budgeted expectations to assess segment performance and allocate resources. The Company’s segment net loss for December 31, 2025, and 2024 consisted of the following: Segment Disclosures for the Years Ended: <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zqNxargZ6uWk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Disclosure (Details)"> <tr style="vertical-align: bottom"> <td> Schedule of segment disclosures</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20250101__20251231_zNgTiPSuvrpe" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20240101__20241231_z4HEqq5BSdk4" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--RevenuesAbstract_iB_zSWnefUFQ999" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; padding-left: 5.4pt">Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS654RGELZqg" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt"> Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">133,222</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">171,596</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_zAJVwrzdZy83" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Net Sales</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">133,222</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">171,596</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CostOfGoodsAndServicesSold_d0_zIltKyF4Nfd8" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Cost of Goods Sold</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">21,645</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GrossProfit_zFmO5lhkslab" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Gross Profit</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">133,222</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">149,951</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SellingGeneralAndAdministrativeExpenseAbstract_iB_zVCqDwAVlzak" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Sales, marketing and support</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--MarketingAndAdvertisingExpense_z53BDaxyoF3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Marketing costs</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">60,695</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">148,093</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ProfessionalFees_zkLKCcv7Rba3" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Professional fees</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">33,108</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">51,838</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AmortizationOfIntangibleAssets_zeredhRgOuQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"> Amortization</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">14,800</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,800</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherGeneralExpense_z8kRiVdBxEV6" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"> Consulting</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">886,105</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">5,133</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_zGr42X9JwM01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> General and Administrative costs</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">31,392</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,459</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_d0_z7GQE5glHTy1" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Loss on Impairment</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z72o8kKvrNNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Income (Loss) Before Taxes</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(892,877</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(69,372</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zqNxargZ6uWk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Disclosure (Details)"> <tr style="vertical-align: bottom"> <td> Schedule of segment disclosures</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20250101__20251231_zNgTiPSuvrpe" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20240101__20241231_z4HEqq5BSdk4" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--RevenuesAbstract_iB_zSWnefUFQ999" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; padding-left: 5.4pt">Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS654RGELZqg" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt"> Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">133,222</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">171,596</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_zAJVwrzdZy83" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Net Sales</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">133,222</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">171,596</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CostOfGoodsAndServicesSold_d0_zIltKyF4Nfd8" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Cost of Goods Sold</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">21,645</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GrossProfit_zFmO5lhkslab" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Gross Profit</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">133,222</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">149,951</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SellingGeneralAndAdministrativeExpenseAbstract_iB_zVCqDwAVlzak" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Sales, marketing and support</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--MarketingAndAdvertisingExpense_z53BDaxyoF3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Marketing costs</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">60,695</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">148,093</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ProfessionalFees_zkLKCcv7Rba3" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Professional fees</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">33,108</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">51,838</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AmortizationOfIntangibleAssets_zeredhRgOuQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"> Amortization</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">14,800</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,800</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherGeneralExpense_z8kRiVdBxEV6" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"> Consulting</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">886,105</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">5,133</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_zGr42X9JwM01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> General and Administrative costs</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">31,392</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,459</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_d0_z7GQE5glHTy1" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Loss on Impairment</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z72o8kKvrNNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Income (Loss) Before Taxes</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(892,877</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(69,372</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>

133222

171596

133222

171596

21645

133222

149951

60695

148093

33108

51838

14800

4800

886105

5133

31392

4459

5000

-892877

-69372

Note 5 – Stockholders' Equity The Company is authorized to issue 75,000,000 shares of common stock, par value .001 per share. As of December 31, 2025, there were 42,690,580 shares of common stock issued and outstanding. Set forth below is information regarding the issuance and sales of securities without registration since inception. No such sales involved the use of an underwriter; no advertising or public solicitation was involved; the securities bear a restrictive legend; and no commissions were paid in connection with the sale of any securities. Since January 1, 2025, we have issued an aggregate of 10,520,580 shares: 9,400,000 shares to 10 people for services, 173,913 shares were issued for an asset, and an aggregate of 946,667 shares were issued to 4 people as cash investors. The related amounts recorded were as follows: shares issued for services — common stock of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250101__20251231__us-gaap--AwardTypeAxis__custom--CommonStocksMember_z6fjYu1l2KWe" title="Number of shares issued for services, value">9,400 and additional paid-in capital of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250101__20251231__us-gaap--AwardTypeAxis__custom--AdditionalPaidInCapitalsMember_zUJRFxp6y3U1" title="Number of shares issued for services, value">754,795; shares issued for cash — common stock of $947 and additional paid-in capital of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--AwardTypeAxis__custom--AdditionalPaidInCapitalsMember_z4iZVFhtzLik" title="Number of shares issued cash investors, value">107,991; and shares issued for asset acquisition — common stock of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20250101__20251231__us-gaap--AwardTypeAxis__custom--CommonStocksMember_zKuiz34capZ4" title="Number of shares issued for asset, value">174 and additional paid-in capital of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20250101__20251231__us-gaap--AwardTypeAxis__custom--AdditionalPaidInCapitalsMember_zIRuRzWs38f3" title="Number of shares issued for asset, value">295,393.The issuances were exempt from registration under Section (4)(a)(2) of the Securities Act as issuances not involving a public offering. Such issuances were made to a limited number of non-affiliated individuals and non-affiliated entities as follows: <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On June 8, 2025, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250607__20250608__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_zT7A6uGSYShf" title="Number of shares issued for services">1,500,000 shares of common stock to a non-affiliated entity for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On June 9, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250607__20250609__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zihhKWzHbCj4" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated individual for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On July 5, 2025, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250704__20250705__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zkbwxgBYvy47" title="Number of shares issued for services">500,000 shares of common stock to a non-affiliated individual for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On July 8, 2025, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250707__20250708__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_zOlDSdBGzTvl" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated entity for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On July 29, 2025, the Company issued 66,667 shares of common stock to a non-affiliated individual for cash.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On August 20, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20250819__20250820__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_z1OQgu4CQdyk" title="Number of shares issued for asset">173,913 shares of common stock to a non-affiliated entity in exchange for an asset.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On September 23, 2025, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250922__20250923__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zT4kL4nuvPp2" title="Number of shares issued for services">200,000 shares of common stock to a non-affiliated individual for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On October 10, 2025, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251009__20251010__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_zrJGkLQMME6b" title="Number of shares issued for services">500,000 shares of common stock to a non-affiliated entity for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On October 15, 2025, the Company issued an aggregate of 1,780,000 shares of common stock, consisting of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251014__20251015__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_zP6j8iZjqkFb" title="Number of shares issued for services">1,500,000 shares issued to a non-affiliated entity for services and 280,000 shares issued to a non-affiliated individual for cash.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On November 1, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251029__20251101__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zNaAku4tQoA2" title="Number of shares issued for services">1,400,000 shares of common stock to a non-affiliated individual for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On November 3, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251102__20251103__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zF16WKEHv729" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated individual for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On November 12, 2025, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251111__20251112__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_z9AyJ5AmvGp" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated individual for services.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">On November 28, 2025, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251127__20251128__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_z5rF9qin2q79" title="Number of shares issued for services">400,000 shares of common stock to a non-affiliated individual for cash.</td></tr></table> On February 5, 2022, the Company issued 230,000 shares of common stock to Andrew Read at $.01 for $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20220204__20220205__srt--CounterpartyNameAxis__custom--AndrewReadMember_zMDOiJKrBqF5" title="Number of shares issued for services, value">2,300. On December 28, 2023, the Company issued 22,000,000 shares of common stock to Andrew Read at $.01 for services. The issuances were exempt from registration by reason of Section (4)(a)(2) of the Securities act as issuances not involving a public offering. The company issued 6,940,000 shares in a Regulation D, Rule 506 offering which was filed with the SEC on March 11, 2022, done in compliance with Section (4)(a)(2) of the 1933 Act, at an offering price of $0.01 per share, resulting in total proceeds of $69,400 and a sale of 6,940,000 shares in aggregate. None of the investors are affiliated with any of our directors, officers or promoters or any beneficial owner of 10% or more of our securities As of December 31, 2025, the Company had 42,690,580 shares of common stock issued and outstanding. Warrants During the year ended December 31, 2025, the Company issued warrants to purchase an aggregate of 946,667 shares of common stock to the Beling Family Trust. No warrants were outstanding as of December 31, 2024. A summary of warrant activity for the year ended December 31, 2025 is as follows: <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfStockholdersEquityNoteWarrantsActivityTextBlock_zoRnriSRawRb" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"> Schedule of warrant activity</td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-size: 10pt; text-align: left">Outstanding at December 31, 2024</td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20250101__20251231_zt4PHVkLaaS" style="font-size: 10pt; text-align: right" title="Warrants outstanding, beginning balance">—</td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td style="vertical-align: middle; font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"> </td> <td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20250101__20251231_zcp511ifsaXc" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, beginning balance">—</td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Granted</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250101__20251231_zs78yz1CjSs5" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Granted">946,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20251231_zPSxBtDT3zo5" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted">0.08</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercised</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_d0_c20250101__20251231_zn2BI6Bbl092" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Exercised">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20251231_zUGdvav0ppm5" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Expired</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20250101__20251231_zYEW8Z5h0h05" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20250101__20251231_ze6jArxK899" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Outstanding at December 31, 2025</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20250101__20251231_z7VwTLrl8zZ9" style="font-size: 10pt; text-align: right" title="Warrants outstanding, ending balance">946,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20250101__20251231_zjSuLHBrCCp4" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, ending balance">0.08</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercisable at December 31, 2025</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231_z4tfERv88sjf" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Exercisable">946,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20251231_z3TVL0Zcf6T9" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable">0.08</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> The weighted average exercise price of warrants granted during the year ended December 31, 2025 was $0.08 per share. The weighted average remaining contractual term of warrants outstanding at December 31, 2025 was approximately <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231_zEYMRGBjg46" title="Weighted average remaining contractual term">2.74 years. Based on the Company’s common stock price of $0.10 per share at December 31, 2025, the aggregate intrinsic value of warrants outstanding and exercisable was $34,000.The following table summarizes warrants outstanding at December 31, 2025: <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zlnryp2tQog8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrants outstanding)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center">Schedule of warrants outstanding </td><td style="text-align: center; font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td><td style="text-align: center; font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td><td style="text-align: center; font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares Under Warrant</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Terms</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 33%; text-align: justify; padding-left: 0.75pt">July 29, 2025</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--WarrantsMember_zUKsdyRt3dp9" style="width: 12%; text-align: right" title="Shares under warrant">66,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--WarrantsMember_z81tlYu8fMRg" style="width: 12%; text-align: right" title="Warrant exercise price">0.30</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 20%; text-align: left; padding-left: 0.75pt">July 29, 2028</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">Cash exercise</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.75pt">September 8, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants1Member_zJEpOjXzrN8h" style="text-align: right" title="Shares under warrant">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants1Member_z3v2509deq0e" style="text-align: right" title="Warrant exercise price">0.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; padding-left: 0.75pt">September 8, 2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Cash exercise</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.75pt">October 15, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants2Member_zQzsFJPMKS2" style="text-align: right" title="Shares under warrant">280,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants2Member_zXmH5BJym2Ma" style="text-align: right" title="Warrant exercise price">0.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; padding-left: 0.75pt">October 15, 2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Cash exercise</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.75pt">November 28, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants3Member_zldLqTrOi3S1" style="text-align: right" title="Shares under warrant">400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants3Member_z6OCiBylo106" style="text-align: right" title="Warrant exercise price">0.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; padding-left: 0.75pt">November 28, 2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Cash exercise</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Total / Weighted Average</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231_z7GVYacUXcT" style="font-weight: bold; text-align: right" title="Shares under warrant">946,667</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231_zUoaEoOueCn9" style="font-weight: bold; text-align: right" title="Warrant exercise price">0.08</td><td style="font-weight: bold; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; padding-left: 0.75pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> </table> We have never utilized an underwriter for an offering of our securities. Other than the securities mentioned above, we have not issued or sold any securities. No stock was issued to related parties during the period.

75000000

0.001

42690580

10520580 9400000

173913

946667

9400

754795

947

107991

174

295393

1500000

1000000

500000

1000000

66667

173913

200000

500000

1780000

1500000

280000

1400000

1000000

400000

230000

0.01

2300

22000000

0.01

6940000

0.01

69400

6940000

42690580

946667

<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfStockholdersEquityNoteWarrantsActivityTextBlock_zoRnriSRawRb" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"> Schedule of warrant activity</td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-size: 10pt; text-align: left">Outstanding at December 31, 2024</td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20250101__20251231_zt4PHVkLaaS" style="font-size: 10pt; text-align: right" title="Warrants outstanding, beginning balance">—</td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td style="vertical-align: middle; font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"> </td> <td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20250101__20251231_zcp511ifsaXc" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, beginning balance">—</td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Granted</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250101__20251231_zs78yz1CjSs5" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Granted">946,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20251231_zPSxBtDT3zo5" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted">0.08</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercised</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_d0_c20250101__20251231_zn2BI6Bbl092" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Exercised">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20251231_zUGdvav0ppm5" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Expired</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20250101__20251231_zYEW8Z5h0h05" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20250101__20251231_ze6jArxK899" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Outstanding at December 31, 2025</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20250101__20251231_z7VwTLrl8zZ9" style="font-size: 10pt; text-align: right" title="Warrants outstanding, ending balance">946,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20250101__20251231_zjSuLHBrCCp4" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, ending balance">0.08</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercisable at December 31, 2025</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231_z4tfERv88sjf" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Exercisable">946,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20251231_z3TVL0Zcf6T9" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable">0.08</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table>

946667

0.08

0 0

946667

0.08

946667

0.08

P2Y8M26D

0.10

34000

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zlnryp2tQog8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrants outstanding)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center">Schedule of warrants outstanding </td><td style="text-align: center; font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td><td style="text-align: center; font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td><td style="text-align: center; font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="text-align: center; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares Under Warrant</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Terms</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 33%; text-align: justify; padding-left: 0.75pt">July 29, 2025</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--WarrantsMember_zUKsdyRt3dp9" style="width: 12%; text-align: right" title="Shares under warrant">66,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--WarrantsMember_z81tlYu8fMRg" style="width: 12%; text-align: right" title="Warrant exercise price">0.30</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 20%; text-align: left; padding-left: 0.75pt">July 29, 2028</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">Cash exercise</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.75pt">September 8, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants1Member_zJEpOjXzrN8h" style="text-align: right" title="Shares under warrant">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants1Member_z3v2509deq0e" style="text-align: right" title="Warrant exercise price">0.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; padding-left: 0.75pt">September 8, 2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Cash exercise</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.75pt">October 15, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants2Member_zQzsFJPMKS2" style="text-align: right" title="Shares under warrant">280,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants2Member_zXmH5BJym2Ma" style="text-align: right" title="Warrant exercise price">0.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; padding-left: 0.75pt">October 15, 2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Cash exercise</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.75pt">November 28, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants3Member_zldLqTrOi3S1" style="text-align: right" title="Shares under warrant">400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--AwardTypeAxis__custom--Warrants3Member_z6OCiBylo106" style="text-align: right" title="Warrant exercise price">0.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; padding-left: 0.75pt">November 28, 2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">Cash exercise</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Total / Weighted Average</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231_z7GVYacUXcT" style="font-weight: bold; text-align: right" title="Shares under warrant">946,667</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231_zUoaEoOueCn9" style="font-weight: bold; text-align: right" title="Warrant exercise price">0.08</td><td style="font-weight: bold; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; padding-left: 0.75pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> </table>

2025-07-29

66667

0.30

2028-07-29

Cash exercise 2025-09-08

200000

0.10

2028-09-08

Cash exercise 2025-10-15

280000

0.05

2028-10-15

Cash exercise 2025-11-28

400000

0.05

2028-11-28

Cash exercise

946667

0.08

Note 6 - Going Concern The Company has incurred recurring losses and, as of December 31, 2025 and December 31, 2024, had accumulated deficits of $1,183,067 and $290,190, respectively in addition to cash used in operating activities of $57,572 and $28,003, respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and achieve profitable operations. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-1183067

-290190

-57572

-28003

Note 7 - Income Taxes The Company recognizes deferred income tax liabilities and assets for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The components of the Company's reconciliation of income taxes computed at the statutory rate of 21% to the income tax amount recorded as of the years ended December 31, 2025 and 2024, are as follows: <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zCWZXKe1L0l2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Reconciliation of income taxes)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: left">Schedule of reconciliation of income taxes </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net Loss Before Taxes</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20250101__20251231_z3lBndlGu9Tc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Loss Before Taxes">(892,877</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20240101__20241231_z5zRJnFP0R9e" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Loss Before Taxes">(69,372</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Tax benefit at federal statutory rate</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20250101__20251231_zmNcb1bOwOq6" style="border-bottom: Black 1pt solid; text-align: right" title="Tax benefit at federal statutory rate">(187,504</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20240101__20241231_zFJqZ1Ign8Hb" style="border-bottom: Black 1pt solid; text-align: right" title="Tax benefit at federal statutory rate">(14,568</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">State income taxes, net of federal benefit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_c20250101__20251231_zr73pCCy9iw6" style="border-bottom: Black 1pt solid; text-align: right" title="State income taxes, net of federal benefit">— </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_c20240101__20241231_z3EVM11vnHR8" style="border-bottom: Black 1pt solid; text-align: right" title="State income taxes, net of federal benefit">— </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_c20250101__20251231_z74DOy6Yzykg" style="text-align: right" title="Change in valuation allowance">187,504</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_c20240101__20241231_zdoMj9FgJy9h" style="text-align: right" title="Change in valuation allowance">14,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Provision from Income Taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--OtherTaxExpenseBenefit_pp0p0_d0_c20250101__20251231_zV800qO9XUMd" style="border-bottom: Black 2.5pt double; text-align: right" title="Provision from Income Taxes">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--OtherTaxExpenseBenefit_pp0p0_d0_c20240101__20241231_zNpmoDXbTi0e" style="border-bottom: Black 2.5pt double; text-align: right" title="Provision from Income Taxes">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zDhfGWkZzBn2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Deferred tax asset)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: left">Schedule of net deferred tax asset </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Deferred Tax Asset</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20251231_zfADzKjtmK14" style="width: 12%; text-align: right" title="Deferred Tax Asset">187,504</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20241231_zj2bRQljqc01" style="width: 12%; text-align: right" title="Deferred Tax Asset">14,568</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Less Valuation Allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20251231_zyW7dze5RqMe" style="text-align: right" title="Less Valuation Allowance">(187,504</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20241231_zNLgY1QPDAWg" style="text-align: right" title="Less Valuation Allowance">(14,568</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21</td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Deferred Tax Asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20251231_zRcUtQGTx1Hc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Deferred Tax Asset">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20241231_z8mJtiE3bUf8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Deferred Tax Asset">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> As of December 31, 2025, the components of the deferred tax asset related to net loss. Due to uncertainties surrounding the Company’s ability to generate future U.S. taxable income to realize these assets, a full valuation allowance has been established to offset the net U.S. deferred tax asset as of December 31, 2025.

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zCWZXKe1L0l2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Reconciliation of income taxes)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: left">Schedule of reconciliation of income taxes </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net Loss Before Taxes</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20250101__20251231_z3lBndlGu9Tc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Loss Before Taxes">(892,877</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20240101__20241231_z5zRJnFP0R9e" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Net Loss Before Taxes">(69,372</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Tax benefit at federal statutory rate</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20250101__20251231_zmNcb1bOwOq6" style="border-bottom: Black 1pt solid; text-align: right" title="Tax benefit at federal statutory rate">(187,504</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20240101__20241231_zFJqZ1Ign8Hb" style="border-bottom: Black 1pt solid; text-align: right" title="Tax benefit at federal statutory rate">(14,568</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">State income taxes, net of federal benefit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_c20250101__20251231_zr73pCCy9iw6" style="border-bottom: Black 1pt solid; text-align: right" title="State income taxes, net of federal benefit">— </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_c20240101__20241231_z3EVM11vnHR8" style="border-bottom: Black 1pt solid; text-align: right" title="State income taxes, net of federal benefit">— </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_c20250101__20251231_z74DOy6Yzykg" style="text-align: right" title="Change in valuation allowance">187,504</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_c20240101__20241231_zdoMj9FgJy9h" style="text-align: right" title="Change in valuation allowance">14,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Provision from Income Taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--OtherTaxExpenseBenefit_pp0p0_d0_c20250101__20251231_zV800qO9XUMd" style="border-bottom: Black 2.5pt double; text-align: right" title="Provision from Income Taxes">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--OtherTaxExpenseBenefit_pp0p0_d0_c20240101__20241231_zNpmoDXbTi0e" style="border-bottom: Black 2.5pt double; text-align: right" title="Provision from Income Taxes">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table>

-892877

-69372

-187504

0.21

-14568

0.21

0.000

187504

0.21

14568

0.21

0.000

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zDhfGWkZzBn2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Deferred tax asset)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: left">Schedule of net deferred tax asset </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Deferred Tax Asset</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20251231_zfADzKjtmK14" style="width: 12%; text-align: right" title="Deferred Tax Asset">187,504</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20241231_zj2bRQljqc01" style="width: 12%; text-align: right" title="Deferred Tax Asset">14,568</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Less Valuation Allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20251231_zyW7dze5RqMe" style="text-align: right" title="Less Valuation Allowance">(187,504</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20241231_zNLgY1QPDAWg" style="text-align: right" title="Less Valuation Allowance">(14,568</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21</td><td style="text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Deferred Tax Asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20251231_zRcUtQGTx1Hc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Deferred Tax Asset">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20241231_z8mJtiE3bUf8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Deferred Tax Asset">— </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table>

187504

0.21

14568

0.21

187504

-0.21

14568

-0.21

0.000

Note 8 - Subsequent Events On January 29, 2026, the Company entered into a Common Stock Purchase Agreement (the “Purchase Agreement”) with RH2 Equity Partners (“RH2”), pursuant to which RH2 has committed to purchase, at the Company’s discretion and subject to specified conditions, up to $<span id="xdx_905_ecustom--CommittedToPurchaseDiscretion_pn6n6_c20260128__20260129__us-gaap--TransactionTypeAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zE82AakmHNO1" title="Committed to purchase discretion">10.0 million of the Company’s common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20260129__us-gaap--TransactionTypeAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1QLMSqRDCNg" title="Common stock par value">0.001 per share. In connection with the Purchase Agreement, the Company filed a registration statement on Form S-1 to register for resale up to <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260128__20260129__us-gaap--TransactionTypeAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zt4QCUoeytFj" title="Number of shares sold">20,000,000 shares of common stock that have been or may be issued to RH2 under the Purchase Agreement. The registered shares are being offered for resale by RH2, and the Company will not receive any proceeds from the resale of such shares. No shares were issued, and no proceeds were received under the Purchase Agreement as of December 31, 2025. The Company evaluated subsequent events through the date the financial statements were issued and determined that no other subsequent events require recognition or disclosure.

10000000

0.001

20000000

false false false false true